Federated Hermes’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Sell |
34,632
-2,412
| -7% | -$141K | ﹤0.01% | 966 |
|
|
2025
Q4 | $2M | Sell |
37,044
-2,063
| -5% | -$99.2K | ﹤0.01% | 962 |
|
|
2025
Q3 | $1.76M | Sell |
39,107
-371
| -0.9% | -$17.3K | ﹤0.01% | 971 |
|
|
2025
Q2 | $1.83M | Sell |
39,478
-7,793,300
| -99% | -$383M | ﹤0.01% | 967 |
|
|
2025
Q1 | $478M | Sell |
7,832,778
-1,101,066
| -12% | -$64.2M | 1.03% | 12 |
|
|
2024
Q4 | $505M | Buy |
8,933,844
+571,107
| +7% | +$31.9M | 1.11% | 8 |
|
|
2024
Q3 | $433M | Buy |
8,362,737
+816,426
| +11% | +$38.3M | 0.95% | 11 |
|
|
2024
Q2 | $313M | Buy |
7,546,311
+3,495,704
| +86% | +$156M | 0.74% | 24 |
|
|
2024
Q1 | $220M | Buy |
4,050,607
+3,794,232
| +1,480% | +$193M | 0.51% | 38 |
|
|
2023
Q4 | $13.2M | Sell |
256,375
-778,548
| -75% | -$40.9M | 0.03% | 492 |
|
|
2023
Q3 | $60.1M | Sell |
1,034,923
-526,695
| -34% | -$32.3M | 0.16% | 164 |
|
|
2023
Q2 | $99.9M | Buy |
1,561,618
+29,026
| +2% | +$1.95M | 0.25% | 85 |
|
|
2023
Q1 | $106M | Buy |
1,532,592
+190,669
| +14% | +$13.4M | 0.27% | 82 |
|
|
2022
Q4 | $96.6M | Sell |
1,341,923
-2,245,695
| -63% | -$169M | 0.27% | 74 |
|
|
2022
Q3 | $255M | Buy |
3,587,618
+35,573
| +1% | +$2.58M | 0.75% | 22 |
|
|
2022
Q2 | $274M | Sell |
3,552,045
-1,525,094
| -30% | -$116M | 0.74% | 20 |
|
|
2022
Q1 | $371M | Buy |
5,077,139
+1,839,065
| +57% | +$123M | 0.84% | 13 |
|
|
2021
Q4 | $202M | Buy |
3,238,074
+2,946,093
| +1,009% | +$173M | 0.38% | 60 |
|
|
2021
Q3 | $17.3M | Buy |
291,981
+70,793
| +32% | +$4.66M | 0.03% | 512 |
|
|
2021
Q2 | $14.8M | Buy |
221,188
+102,943
| +87% | +$6.71M | 0.03% | 555 |
|
|
2021
Q1 | $7.46M | Sell |
118,245
-3,461,227
| -97% | -$215M | 0.01% | 741 |
|
|
2020
Q4 | $222M | Sell |
3,579,472
-82,528
| -2% | -$5.07M | 0.45% | 40 |
|
|
2020
Q3 | $221M | Buy |
3,662,000
+1,122,287
| +44% | +$67.5M | 0.52% | 36 |
|
|
2020
Q2 | $149M | Buy |
2,539,713
+2,398,525
| +1,699% | +$143M | 0.37% | 51 |
|
|
2020
Q1 | $7.87M | Buy |
141,188
+99,940
| +242% | +$6.11M | 0.02% | 530 |
|
|
2019
Q4 | $2.65M | Sell |
41,248
-317,725
| -89% | -$18.2M | 0.01% | 942 |
|
|
2019
Q3 | $18.2M | Sell |
358,973
-295,392
| -45% | -$13.9M | 0.04% | 391 |
|
|
2019
Q2 | $29.7M | Sell |
654,365
-13,610
| -2% | -$634K | 0.07% | 278 |
|
|
2019
Q1 | $31.9M | Sell |
667,975
-74,593
| -10% | -$3.72M | 0.08% | 259 |
|
|
2018
Q4 | $38.6M | Buy |
742,568
+153,414
| +26% | +$8.24M | 0.11% | 214 |
|
|
2018
Q3 | $36.6M | Buy |
589,154
+207,086
| +54% | +$12.3M | 0.09% | 246 |
|
|
2018
Q2 | $21.1M | Buy |
382,068
+110,541
| +41% | +$5.97M | 0.06% | 240 |
|
|
2018
Q1 | $17.2M | Sell |
271,527
-63,887
| -19% | -$4.11M | 0.05% | 287 |
|
|
2017
Q4 | $20.6M | Buy |
335,414
+144,110
| +75% | +$9.01M | 0.06% | 248 |
|
|
2017
Q3 | $12.2M | Buy |
191,304
+104,319
| +120% | +$6.09M | 0.04% | 363 |
|
|
2017
Q2 | $4.85M | Sell |
86,985
-17,536
| -17% | -$954K | 0.01% | 580 |
|
|
2017
Q1 | $5.68M | Sell |
104,521
-1,401,684
| -93% | -$76.9M | 0.02% | 541 |
|
|
2016
Q4 | $88M | Buy |
1,506,205
+1,401,125
| +1,333% | +$76.6M | 0.26% | 67 |
|
|
2016
Q3 | $5.67M | Sell |
105,080
-950,182
| -90% | -$61M | 0.02% | 538 |
|
|
2016
Q2 | $77.6M | Buy |
1,055,262
+10,703
| +1% | +$756K | 0.23% | 79 |
|
|
2016
Q1 | $66.7M | Buy |
1,044,559
+965,542
| +1,222% | +$60.9M | 0.21% | 85 |
|
|
2015
Q4 | $5.43M | Sell |
79,017
-5,985
| -7% | -$396K | 0.02% | 552 |
|
|
2015
Q3 | $5.03M | Sell |
85,002
-865,583
| -91% | -$54.9M | 0.02% | 554 |
|
|
2015
Q2 | $63.3M | Buy |
950,585
+187,144
| +25% | +$12.3M | 0.19% | 105 |
|
|
2015
Q1 | $49.2M | Buy |
763,441
+708,899
| +1,300% | +$44.4M | 0.15% | 139 |
|
|
2014
Q4 | $3.22M | Sell |
54,542
-2,491,150
| -98% | -$140M | 0.01% | 771 |
|
|
2014
Q3 | $130M | Sell |
2,545,692
-117,108
| -4% | -$5.85M | 0.42% | 45 |
|
|
2014
Q2 | $129M | Sell |
2,662,800
-4,212
| -0.2% | -$208K | 0.41% | 46 |
|
|
2014
Q1 | $139M | Buy |
2,667,012
+28,325
| +1% | +$1.51M | 0.46% | 42 |
|
|
2013
Q4 | $140M | Sell |
2,638,687
-117,268
| -4% | -$5.97M | 0.49% | 43 |
|
|
2013
Q3 | $128M | Sell |
2,755,955
-3,028,164
| -52% | -$133M | 0.49% | 40 |
|
|
2013
Q2 | $258M | Buy |
+5,784,119
| New | +$251M | 1.02% | 18 |
|
Other funds holding BMY
VCM
VPM
Federated Hermes's BMY Position: Q1 2026 in Review
Federated Hermes reduced its Bristol-Myers Squibb (BMY) stake by 6.5% in Q1 2026, selling an estimated $141K and leaving 34,632 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #966.
Federated Hermes first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $505M in Q4 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Federated Hermes held 34,632 shares of Bristol-Myers Squibb worth $2.1M as of Q1 2026.
- Federated Hermes sold 2,412 Bristol-Myers Squibb shares in Q1 2026, an estimated $141K.
- Bristol-Myers Squibb made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #966 holding.
- Federated Hermes first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Bristol-Myers Squibb position peaked at $505M in Q4 2024.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.